Delivery Order SPE2DB20D3103-SPE2DB26FL5R4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,029.63 on September 22, 2025, for the supply of Promacta 75 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $17,672.24 delivery order to AmerisourceBergen Drug Corp for Promacta 25 mg tablets (30-unit package) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units, with a ceiling value of $8,026.53 and a firm fixed price structure. This award represents a non-set-aside competitive procurement that will be performed at the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $13,254.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Promacta 25 mg tablets (30-count unit of use packaging). The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $4,418.06 to AmerisourceBergen Drug Corp for Promacta 25 mg tablets (30-count units) under a firm fixed-price contract, with an ultimate completion date of November 13, 2025. This non-set-aside delivery order represents a competitive award to the pharmaceutical distributor, which maintains its corporate office in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,418.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Promacta 25 mg tablets (30-count units) with a completion date of November 10, 2025. This delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $12,029.63 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This competitive, firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a continuation of the company's pharmaceutical supply services to the federal government. The award was executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. The contract has a ceiling value of $8,026.53 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 15, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it...
- The Defense Logistics Agency awarded a delivery order valued at $13,965.30 to AmerisourceBergen Drug Corp for the supply of Promacta 12.5 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on November 7, 2025, with an ultimate completion date of December 2, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $8,026.53 with firm fixed pricing and is scheduled for completion by November 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL5R4Delivery Order
The Defense Logistics Agency awarded a $24,079.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Promacta 50 mg tablets (30-count units). The contract, which represents a non-competitive set-aside award, is scheduled for completion by December 3, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling value through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health System. The company maintains an extensive portfolio of federal contracts supplying pharmaceuticals and medical supplies to military and veteran healthcare systems. This particular order for Promacta, an immunosuppressant medication used to treat thrombocytopenia, supports the military's pharmaceutical supply chain requirements. The award reflects AmerisourceBergen's ongoing role as a primary pharmaceutical supplier under the DLA's global pharmaceutical support framework, which enables flexible fulfillment of medical needs across multiple federal healthcare agencies and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 11/10/25 |